Imexpharm Corporation (HOSE: IMP)
Vietnam
· Delayed Price · Currency is VND 41,400
-400 (-0.96%)
At close: Nov 21, 2024
Imexpharm Cash Flow Statement
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 272,602 | 299,556 | 223,540 | 189,095 | 209,697 | 162,387 | Upgrade
|
| Depreciation & Amortization | 104,097 | 81,987 | 60,386 | 60,412 | 53,361 | 41,209 | Upgrade
|
| Other Amortization | 1,643 | 654.92 | - | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | -8,126 | -22,410 | -19,861 | -18,628 | -9,977 | -14,278 | Upgrade
|
| Other Operating Activities | -53,759 | -32,171 | -6,126 | -45,582 | -1,784 | -25,475 | Upgrade
|
| Change in Accounts Receivable | -117,238 | -30,534 | 20,136 | 115,759 | -60,836 | -64,062 | Upgrade
|
| Change in Inventory | 1,941 | -260,749 | 52,398 | -66,129 | -75,247 | -25,446 | Upgrade
|
| Change in Accounts Payable | 78,471 | 25,481 | 39,580 | -2,831 | -49,526 | 6,750 | Upgrade
|
| Change in Other Net Operating Assets | -40,421 | -101,351 | 7,018 | -2,159 | 7,465 | -14,253 | Upgrade
|
| Operating Cash Flow | 239,210 | -39,535 | 378,603 | 234,881 | 73,153 | 66,590 | Upgrade
|
| Operating Cash Flow Growth | - | - | 61.19% | 221.08% | 9.86% | -49.59% | Upgrade
|
| Capital Expenditures | -80,552 | -63,530 | -99,353 | -52,857 | -89,685 | -131,125 | Upgrade
|
| Sale of Property, Plant & Equipment | 5,033 | 2,533 | 582.73 | 8,655 | 4,889 | 9,216 | Upgrade
|
| Investment in Securities | 118,300 | 118,300 | -118,327 | -244,945 | -105,940 | -32,087 | Upgrade
|
| Other Investing Activities | 7,847 | 21,817 | 17,794 | 10,106 | 6,585 | 7,075 | Upgrade
|
| Investing Cash Flow | -41,672 | 79,121 | -199,304 | -83,142 | -136,476 | -120,623 | Upgrade
|
| Short-Term Debt Issued | - | 229,739 | 59,803 | - | 408,998 | 218,888 | Upgrade
|
| Long-Term Debt Issued | - | - | - | 324,785 | - | - | Upgrade
|
| Total Debt Issued | 351,294 | 229,739 | 59,803 | 324,785 | 408,998 | 218,888 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | - | -181,309 | Upgrade
|
| Long-Term Debt Repaid | - | -275,298 | -231,514 | -190,282 | -315,649 | - | Upgrade
|
| Total Debt Repaid | -326,758 | -275,298 | -231,514 | -190,282 | -315,649 | -181,309 | Upgrade
|
| Net Debt Issued (Repaid) | 24,536 | -45,558 | -171,711 | 134,503 | 93,348 | 37,579 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 29,632 | - | Upgrade
|
| Repurchase of Common Stock | - | - | - | - | - | -140 | Upgrade
|
| Common Dividends Paid | -136,676 | -66,672 | -100,007 | -100,007 | -49,387 | -98,803 | Upgrade
|
| Financing Cash Flow | -112,140 | -112,230 | -271,718 | 34,496 | 73,592 | -61,363 | Upgrade
|
| Foreign Exchange Rate Adjustments | 31.24 | -0.59 | -9.19 | -230.63 | -36.79 | -5.1 | Upgrade
|
| Net Cash Flow | 85,429 | -72,645 | -92,428 | 186,004 | 10,233 | -115,401 | Upgrade
|
| Free Cash Flow | 158,658 | -103,064 | 279,250 | 182,024 | -16,531 | -64,535 | Upgrade
|
| Free Cash Flow Growth | - | - | 53.41% | - | - | - | Upgrade
|
| Free Cash Flow Margin | 7.34% | -5.17% | 16.99% | 14.37% | -1.21% | -4.60% | Upgrade
|
| Free Cash Flow Per Share | 1030.18 | -669.21 | 1813.19 | 1181.89 | -110.47 | -434.95 | Upgrade
|
| Cash Interest Paid | 3,279 | 6,700 | 4,475 | 4,227 | 5,310 | 3,707 | Upgrade
|
| Cash Income Tax Paid | 69,071 | 83,992 | 59,624 | 45,310 | 40,856 | 42,339 | Upgrade
|
| Levered Free Cash Flow | 84,363 | -69,934 | 274,201 | 211,391 | -18,044 | -36,455 | Upgrade
|
| Unlevered Free Cash Flow | 86,376 | -66,162 | 276,573 | 214,826 | -14,664 | -34,125 | Upgrade
|
| Change in Net Working Capital | 161,751 | 323,429 | -130,228 | -60,976 | 142,437 | 71,110 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.